Chondrial Therapeutics
Indianapolis, US · Founded 2013
Founders & leadership
SR
Steven Reed PlumpMember in a member-managed LLC
RM
Ronald Mark PayneMember in a member-managed LLC
Reported raises · per SEC filings
Form D private placements$600K disclosed across 2 rounds · 2014
▶$500KraisedAug 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedAug 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ronald Mark PayneExecutive Officer, Director
- Steven Reed PlumpExecutive Officer
- Offering amount
- $1M
- Amount sold
- $500K
- Minimum investment
- $500K
- Incorporated
- Limited Liability Company, Indiana, 2013
- Federal exemptions
- 06b
▶$100KraisedJun 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$100KraisedJun 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven Reed PlumpDirector
- Ronald Mark PayneDirector
- Offering amount
- $100K
- Amount sold
- $100K
- First sale
- Mar 2014
- Incorporated
- Limited Liability Company, Indiana, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Chondrial Therapeutics raised?
- Chondrial Therapeutics has disclosed $600K raised across 2 rounds.
- Where is Chondrial Therapeutics headquartered?
- Chondrial Therapeutics is headquartered in Indianapolis, US.